mFluiDx develops the SIMPLE CHIP, a point-of-care molecular diagnostic tool that utilizes microfluidics and isothermal amplification to deliver PCR-equivalent results for multiple pathogens within 7 to 15 minutes. This technology addresses the need for rapid, low-cost testing in decentralized settings like small clinics and pharmacies, achieving cost parity with traditional rapid antigen tests.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional PCR-based molecular diagnostic testing often requires specialized laboratory equipment, trained personnel, and lengthy turnaround times, limiting accessibility in point-of-care settings. Existing rapid antigen tests offer faster results but typically exhibit lower sensitivity and specificity compared to PCR.
Solution
mFluiDx is developing the SIMPLE CHIP, a point-of-care molecular diagnostic platform that delivers PCR-equivalent results for multiple pathogens in 7 to 15 minutes. The system utilizes microfluidics and isothermal amplification to achieve rapid, sensitive, and specific detection of viral and bacterial pathogens directly at the point of care. The SIMPLE CHIP integrates sample preparation, amplification, and detection into a single-use disposable cartridge, minimizing user intervention and reducing the risk of contamination. The platform is designed to be low-cost and fully automated, enabling decentralized testing in settings such as small clinics, pharmacies, and resource-limited environments.
Target Audience
The primary target audience includes healthcare providers in primary care clinics, pharmacies, and other point-of-care settings, as well as organizations involved in disease surveillance and rapid response in resource-limited environments.
Features
- Integrated microfluidic cartridge for automated sample preparation and multi-target detection
- Isothermal amplification technology providing PCR-equivalent sensitivity and specificity
- Rapid turnaround time of 7-15 minutes from sample to result
- Low-cost consumable cartridge and reader instrument
- Ability to detect multiple infectious agents (viral and/or bacterial) from a single sample
- Portable and easy-to-use platform suitable for decentralized testing